InvestorsHub Logo
Followers 743
Posts 61822
Boards Moderated 10
Alias Born 10/05/2009

Re: Tiger Money post# 14038

Friday, 03/13/2020 11:39:31 PM

Friday, March 13, 2020 11:39:31 PM

Post# of 20017
I am pretty sure the financials will be a merged company financials for 2 years signed by the new CEO now listed at OTCMarkets.com, James Hovis, using Dec 31st and as the year end. That timing, and need for time to audited annuals for a year end close Dec 31st, also explains the Custodian discharge delay.

They needed the Custodian resigned/discharged, and the new officers and directors named at the Nevada SOS before filling financials. WE are on watch for that next.

Once that is done, I expect an S-1 SEC registration which includes a form 10, to go back to fully SEC reporting, K-fillings for financials and an asset exchange for preferred voting shares with CCA, LLC shareholders.

That would enable the removal of the OTCmarkets CE.

They had the custodian change the company name as the bought the web sites, so they could lock down the NDT Pharmaceuticals, Inc., name for use on the web sites, and then they needed to do the contract switch from CCA, LLC to NDT Pharmaceuticals Inc with UPennMed and both sides legal teams, and then use the new company name for the S-1 registration with Form 10, and K fillings of audited financials and and asset exchanges.

All that needed to be done in a certain order. And 2 years of Audited year end financials for a newly merged entity of two companies in OTC takes a while.

It's only been 9-10 weeks to do those since the year end.

I bought more shares every day this week. Will be buying more next week also.


All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.